PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31795195-2	2019	KRAS/NRAS mutations are common in ICC tumours and 6-32% of patients also have isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) gene mutations associated with metabolic changes.	Isocitrates	78-88	isocitrate dehydrogenase (NADP(+)) 2	Homo sapiens	121-125	
32055803-1	2020	Isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) are key metabolic enzymes that convert isocitrate to alpha-ketoglutarate (alphaKG).	Isocitrates	88-98	isocitrate dehydrogenase (NADP(+)) 2	Homo sapiens	43-47	
31810230-1	2019	Chondrosarcomas are chemo- and radiotherapy resistant and frequently harbor mutations in isocitrate dehydrogenase (IDH1 or IDH2), causing increased levels of D-2-hydroxyglutarate (D-2-HG).	Isocitrates	89-99	isocitrate dehydrogenase (NADP(+)) 2	Homo sapiens	123-127	
31632056-0	2019	Detection Of Mutations In The Isocitrate Dehydrogenase Genes (IDH1/IDH2) Using castPCRTM In Patients With AML And Their Clinical Impact In Mexico City.	Isocitrates	30-40	isocitrate dehydrogenase (NADP(+)) 2	Homo sapiens	67-71